N- (2-aminophenyl)-4-[N-(pyridine-3-yl)-me thoxycarbonyl-aminomethyl]-benzamide (MS-275)polymorph B
Details for Australian Patent Application No. 2009286982 (hide)
International Classifications
Event Publications
17 March 2011 PCT application entered the National Phase
PCT publication WO2010/022988 Priority application(s): WO2010/022988
23 June 2011 Application Accepted
Published as AU-B-2009286982
6 October 2011 Alteration of Name
The name of the applicant has been altered to Bayer Pharma Aktiengesellschaft
20 October 2011 Standard Patent Sealed
8 December 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 17 Nov 2011. Address for service in Australia - Davies Collison Cave Level 14 255 Elizabeth Street Sydney NSW 2000 2010
26 April 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 17 Nov 2011
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser